...
search icon
tech-img

Bio-Techne Corp, Common Stock

TECH

NSQ

$54.33

-$1.89

(-3.36%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$8.83B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
122.2174
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.99M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.56%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.39
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$45.87 L
$80.52 H
$54.33

About Bio-Techne Corp, Common Stock

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameTECHSectorS&P500
1-Week Return0.61%-0.45%1.74%
1-Month Return-7.21%0.84%1.53%
3-Month Return13.35%3.76%10.03%
6-Month Return-12.02%-8.39%8.8%
1-Year Return-24.12%-12.43%15.84%
3-Year Return-34.82%7.94%60.63%
5-Year Return-14.12%26.32%84.52%
10-Year Return126.38%90.01%225.32%

Financials

Jun '21Jun '22Jun '23Jun '24Jun '255YR TREND
Total Revenue931.03M1.11B1.14B1.16B1.22B[{"date":"2021-06-30","value":76.34,"profit":true},{"date":"2022-06-30","value":90.65,"profit":true},{"date":"2023-06-30","value":93.2,"profit":true},{"date":"2024-06-30","value":95.03,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Cost of Revenue298.18M349.10M366.89M389.33M429.36M[{"date":"2021-06-30","value":69.45,"profit":true},{"date":"2022-06-30","value":81.31,"profit":true},{"date":"2023-06-30","value":85.45,"profit":true},{"date":"2024-06-30","value":90.68,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Gross Profit632.85M756.50M769.82M769.73M790.27M[{"date":"2021-06-30","value":80.08,"profit":true},{"date":"2022-06-30","value":95.73,"profit":true},{"date":"2023-06-30","value":97.41,"profit":true},{"date":"2024-06-30","value":97.4,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Gross Margin67.97%68.42%67.72%66.41%64.80%[{"date":"2021-06-30","value":99.34,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":98.98,"profit":true},{"date":"2024-06-30","value":97.06,"profit":true},{"date":"2025-06-30","value":94.7,"profit":true}]
Operating Expenses395.55M459.91M470.87M563.04M976.83M[{"date":"2021-06-30","value":40.49,"profit":true},{"date":"2022-06-30","value":47.08,"profit":true},{"date":"2023-06-30","value":48.2,"profit":true},{"date":"2024-06-30","value":57.64,"profit":true},{"date":"2025-06-30","value":100,"profit":true}]
Operating Income149.55M296.59M298.94M206.69M242.80M[{"date":"2021-06-30","value":50.03,"profit":true},{"date":"2022-06-30","value":99.21,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":69.14,"profit":true},{"date":"2025-06-30","value":81.22,"profit":true}]
Total Non-Operating Income/Expense(102.60M)(5.72M)31.91M(33.41M)(144.34M)[{"date":"2021-06-30","value":-321.53,"profit":false},{"date":"2022-06-30","value":-17.92,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-104.7,"profit":false},{"date":"2025-06-30","value":-452.34,"profit":false}]
Pre-Tax Income148.18M301.39M338.66M185.69M98.46M[{"date":"2021-06-30","value":43.75,"profit":true},{"date":"2022-06-30","value":88.99,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":54.83,"profit":true},{"date":"2025-06-30","value":29.07,"profit":true}]
Income Taxes8.59M38.29M53.22M17.58M-[{"date":"2021-06-30","value":16.14,"profit":true},{"date":"2022-06-30","value":71.95,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":33.04,"profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Income After Taxes139.59M263.10M285.44M168.10M-[{"date":"2021-06-30","value":48.9,"profit":true},{"date":"2022-06-30","value":92.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.89,"profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Income From Continuous Operations139.59M263.10M285.44M168.10M73.40M[{"date":"2021-06-30","value":48.9,"profit":true},{"date":"2022-06-30","value":92.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.89,"profit":true},{"date":"2025-06-30","value":25.71,"profit":true}]
Income From Discontinued Operations-----[{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true}]
Net Income140.41M272.05M285.26M168.10M73.40M[{"date":"2021-06-30","value":49.22,"profit":true},{"date":"2022-06-30","value":95.37,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.93,"profit":true},{"date":"2025-06-30","value":25.73,"profit":true}]
EPS (Diluted)1.691.982.001.781.93[{"date":"2021-06-30","value":84.5,"profit":true},{"date":"2022-06-30","value":99,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":89,"profit":true},{"date":"2025-06-30","value":96.5,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TECH
Cash Ratio 0.92
Current Ratio 3.46
Quick Ratio 2.38

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TECH
ROA (LTM) 6.30%
ROE (LTM) 3.68%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TECH
Debt Ratio Lower is generally better. Negative is bad. 0.25
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TECH
Trailing PE 122.22
Forward PE 27.55
P/S (TTM) 7.17
P/B 4.60
Price/FCF 94
EV/R 7.47
EV/Ebitda 42.03
PEG 0.75

FAQs

What is Bio-Techne Corp share price today?

Bio-Techne Corp (TECH) share price today is $54.33

Can Indians buy Bio-Techne Corp shares?

Yes, Indians can buy shares of Bio-Techne Corp (TECH) on Vested. To buy Bio-Techne Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TECH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bio-Techne Corp be purchased?

Yes, you can purchase fractional shares of Bio-Techne Corp (TECH) via the Vested app. You can start investing in Bio-Techne Corp (TECH) with a minimum investment of $1.

How to invest in Bio-Techne Corp shares from India?

You can invest in shares of Bio-Techne Corp (TECH) via Vested in three simple steps:

  • Click on Sign Up or Invest in TECH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bio-Techne Corp shares
What is Bio-Techne Corp 52-week high and low stock price?

The 52-week high price of Bio-Techne Corp (TECH) is $80.52. The 52-week low price of Bio-Techne Corp (TECH) is $45.87.

What is Bio-Techne Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Bio-Techne Corp (TECH) is 122.2174

What is Bio-Techne Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bio-Techne Corp (TECH) is 4.60

What is Bio-Techne Corp dividend yield?

The dividend yield of Bio-Techne Corp (TECH) is 0.56%

What is the Market Cap of Bio-Techne Corp?

The market capitalization of Bio-Techne Corp (TECH) is $8.83B

What is Bio-Techne Corp’s stock symbol?

The stock symbol (or ticker) of Bio-Techne Corp is TECH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top